Epidemiologic classification of human papillomavirus types associated with cervical cancer.
By N. Muñoz, F. Bosch, S. de Sanjosé, R. Herrero, X. Castellsagué, K. Shah, P. Snijders, C. Meijer. New England Journal of Medicine, 2003
6,445 citations recorded by the source corpus.
Subfields: Epidemiology, Obstetrics and Gynecology, Otorhinolaryngology
View Paper: https://www.semanticscholar.org/paper/e01cc0515d46c363ed0fbe5ba50ee4316ea219bf
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Epidemiology
- M. Stanley
- J. Doorbar
- Silvia Franceschi
- G. Clifford
- Ignacio G. Bravo
- Luisa Lina Villa
- M. Stoler
- L. Koutsky
In Obstetrics and Gynecology
In Otorhinolaryngology
Citations in the corpus
- Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women of 30 years and older (2009, background): “It is now well-established and widely, if not universally, accepted that virtually all cervical cancer and its immediate precancerous lesions arise from persisting cervical infections by 15 cancer-associated (high-risk or hr) human papillomavirus (hrHPV) genotypes.(1,2) The most important of these H”
- Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: A meta‐analysis (2009, background): “Estimation of HPV prevalence Type-specific prevalence is presented for (i) 15 high-risk HPV types, namely 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68, 73 and 82; and (ii) low-risk HPV Types 6 and 11.(23) No other type was found in more than 0.”
- The biology and life-cycle of human papillomaviruses. (2012, background): “Several other HPV types also belong to the high-risk clade based on evolutionary similarity to the known cancer-causing types [44,45] (shaded pink in Fig.”